Morgan Stanley
VIOV icon

Morgan Stanley’s Vanguard S&P Small-Cap 600 Value ETF VIOV Stock Holding History

Morgan Stanley’s Portfolio VIOV Stock Details VIOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.7M Buy
389,990
+39,284
+11% +$4.08M ﹤0.01% 2327
2025
Q4 		$34.3M Sell
350,706
-374
-0.1% -$36.1K ﹤0.01% 2444
2025
Q3 		$33.4M Buy
351,080
+574
+0.2% +$52.5K ﹤0.01% 2386
2025
Q2 		$30M Buy
350,506
+26,680
+8% +$2.17M ﹤0.01% 2412
2025
Q1 		$27.2M Buy
323,826
+9,795
+3% +$888K ﹤0.01% 2382
2024
Q4 		$29.3M Buy
314,031
+11,174
+4% +$1.07M ﹤0.01% 2366
2024
Q3 		$28M Buy
302,857
+9,695
+3% +$866K ﹤0.01% 2451
2024
Q2 		$24.5M Sell
293,162
-3,353
-1% -$284K ﹤0.01% 2438
2024
Q1 		$26.2M Sell
296,515
-297,951
-50% -$25.4M ﹤0.01% 2402
2023
Q4 		$52.6M Buy
594,466
+306,329
+106% +$24.1M ﹤0.01% 2393
2023
Q3 		$22.2M Sell
288,137
-3,043
-1% -$250K ﹤0.01% 2337
2023
Q2 		$23.9M Sell
291,180
-1,165
-0.4% -$92.1K ﹤0.01% 2293
2023
Q1 		$23.6M Sell
292,345
-11,795
-4% -$994K ﹤0.01% 2242
2022
Q4 		$23.9M Sell
304,140
-8,304
-3% -$662K ﹤0.01% 2164
2022
Q3 		$22.3M Buy
312,444
+15,770
+5% +$1.26M ﹤0.01% 2070
2022
Q2 		$22.8M Sell
296,674
-11,888
-4% -$987K ﹤0.01% 2141
2022
Q1 		$27.3M Buy
308,562
+3,402
+1% +$300K ﹤0.01% 1792
2021
Q4 		$27.5M Buy
305,160
+8,718
+3% +$790K ﹤0.01% 1839
2021
Q3 		$25.8M Buy
296,442
+2,324
+0.8% +$203K ﹤0.01% 1820
2021
Q2 		$26.8M Buy
294,118
+38,908
+15% +$3.52M ﹤0.01% 1846
2021
Q1 		$22.2M Sell
255,210
-11,038
-4% -$903K ﹤0.01% 1810
2020
Q4 		$18.7M Buy
266,248
+66,678
+33% +$4.2M ﹤0.01% 1867
2020
Q3 		$10.6M Buy
199,570
+5,594
+3% +$305K ﹤0.01% 1977
2020
Q2 		$10.1M Buy
193,976
+104,460
+117% +$5.08M ﹤0.01% 1955
2020
Q1 		$3.87M Buy
89,516
+37,142
+71% +$2.22M ﹤0.01% 2693
2019
Q4 		$3.64M Sell
52,374
-2,492
-5% -$167K ﹤0.01% 3528
2019
Q3 		$3.56M Buy
54,866
+1,806
+3% +$115K ﹤0.01% 3251
2019
Q2 		$3.4M Buy
53,060
+1,592
+3% +$102K ﹤0.01% 3306
2019
Q1 		$3.28M Sell
51,468
-8,590
-14% -$547K ﹤0.01% 3122
2018
Q4 		$3.41M Buy
60,058
+9,960
+20% +$637K ﹤0.01% 3307
2018
Q3 		$3.6M Buy
50,098
+368
+0.7% +$26.8K ﹤0.01% 3520
2018
Q2 		$3.51M Buy
49,730
+9,532
+24% +$658K ﹤0.01% 3564
2018
Q1 		$2.62M Buy
40,198
+5,780
+17% +$383K ﹤0.01% 3714
2017
Q4 		$2.28M Buy
34,418
+5,318
+18% +$345K ﹤0.01% 3918
2017
Q3 		$1.86M Buy
29,100
+1,058
+4% +$63.7K ﹤0.01% 3955
2017
Q2 		$1.7M Buy
28,042
+4,140
+17% +$247K ﹤0.01% 3944
2017
Q1 		$1.43M Buy
23,902
+8,488
+55% +$509K ﹤0.01% 4103
2016
Q4 		$928K Buy
15,414
+11,876
+336% +$669K ﹤0.01% 4519
2016
Q3 		$191K Sell
3,538
-826
-19% -$43.7K ﹤0.01% 5040
2016
Q2 		$219K Sell
4,364
-17,060
-80% -$843K ﹤0.01% 4888
2016
Q1 		$1.05M Buy
21,424
+244
+1% +$10.9K ﹤0.01% 3901
2015
Q4 		$994K Buy
21,180
+15,754
+290% +$751K ﹤0.01% 4048
2015
Q3 		$245K Sell
5,426
-788
-13% -$38K ﹤0.01% 4990
2015
Q2 		$317K Buy
6,214
+324
+6% +$16.6K ﹤0.01% 4985
2015
Q1 		$302K Buy
5,890
+642
+12% +$32.1K ﹤0.01% 4968
2014
Q4 		$266K Sell
5,248
-68
-1% -$3.32K ﹤0.01% 5073
2014
Q3 		$247K Sell
5,316
-1,142
-18% -$55.5K ﹤0.01% 5025
2014
Q2 		$322K Buy
6,458
+256
+4% +$12.3K ﹤0.01% 4900
2014
Q1 		$303K Buy
6,202
+1,182
+24% +$56K ﹤0.01% 4883
2013
Q4 		$240K Sell
5,020
-9,764
-66% -$449K ﹤0.01% 4935
2013
Q3 		$652K Buy
14,784
+2,172
+17% +$92.9K ﹤0.01% 4144
2013
Q2 		$509K Buy
+12,612
New +$496K ﹤0.01% 4246

Other funds holding VIOV

AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Morgan Stanley's VIOV Position: Q1 2026 in Review

Morgan Stanley increased its Vanguard S&P Small-Cap 600 Value ETF (VIOV) stake by 11% in Q1 2026, buying an estimated $4.08M and bringing the position to 389,990 shares worth $39.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Morgan Stanley first reported a position in VIOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.6M in Q4 2023. 214 funds tracked by Wall St. Rank hold VIOV as of Q1 2026.

  • Morgan Stanley held 389,990 shares of Vanguard S&P Small-Cap 600 Value ETF worth $39.7M as of Q1 2026.
  • Morgan Stanley bought 39,284 Vanguard S&P Small-Cap 600 Value ETF shares in Q1 2026, an estimated $4.08M.
  • Vanguard S&P Small-Cap 600 Value ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2327 holding.
  • Morgan Stanley first reported a position in Vanguard S&P Small-Cap 600 Value ETF in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Vanguard S&P Small-Cap 600 Value ETF position peaked at $52.6M in Q4 2023.
  • 214 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 Value ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.